BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15934984)

  • 21. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
    Lowder JN; Whelton P
    Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of cadaveric renal allografts contaminated before transplantation.
    Sharma AK; Smith G; Smith D; Sinha S; Rustom R; Sells RA; Hammad A; Bakran A
    Transpl Int; 2005 Jul; 18(7):824-7. PubMed ID: 15948862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
    Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
    Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
    Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
    Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
    Phillips S; MacDougall C; Holdford DA
    Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial contamination of peripheral blood progenitor cells for transplantation.
    Jestice HK; Farrington M; Hunt C; Matthews I; Scott MA; Foreman J; Marcus RE
    Transfus Med; 1996 Jun; 6(2):103-10. PubMed ID: 8809956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
    Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
    Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
    Cheah PL; Ong CW; Crispin P
    Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation.
    Nifong TP; Ehmann WC; Mierski JA; Domen RE; Rybka WB
    Arch Pathol Lab Med; 2003 Jan; 127(1):e19-21. PubMed ID: 12562288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do anterior cruciate ligament allograft culture results correlate with clinical infections?
    Centeno JM; Woolf S; Reid JB; Lubowitz JH
    Arthroscopy; 2007 Oct; 23(10):1100-3. PubMed ID: 17916476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R
    Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.